mexA (PA0425, P52477) notes

Review session 2026-11-05 (PseudoCAP IBA-seed protocol, tier 2)

Fetched with just fetch-gene PSEAE P52477 --alias mexA; accession matches the
worklist. Reviewed Swiss-Prot entry. No deep-research provider was used. Cached
papers: PMID:33009415, PMID:30944318 and PMID:11114896 have full text;
PMID:8540696 (the PseudoCAP seed paper), PMID:25901994, PMID:9973347 and
PMID:15226509 are abstract-only (the PMC copy of PMID:8540696 returned no text).
The PubMed MCP search returned API errors.

Literature

Decisions

PseudoCAP IBA-seed assessment

PTN node node term n_seeds leaf IBAs seed annotation (term, evidence, PMID) verdict rationale other seeds IBD stands without this seed?
PTN001249140 GO:0046677 response to antibiotic 6 38 (12 taxa) GO:0046677, IDA, PMID:8540696 (PseudoCAP) SOUND Abstract: mexA null mutants accumulate more tetracycline, norfloxacin and benzylpenicillin and are more susceptible to beta-lactams. The term is right; the experiments are on null and overproducing mutants, so the code should be IMP (PSEUDOCAP WRONG_EVIDENCE_CODE, PROBABLE: abstract only). E. coli AcrA (P0AE06; EcoCyc IMP/IGI), E. coli MdtE (P37636; EcoCyc IMP), MexE (Q9I0Y9; IGI), MexC (G3XD25; IGI), MexX (G3XD21; PseudoCAP EXP/IMP) Yes

No GO_CENTRAL defect. The node-level assessment (clade of RND-pump membrane fusion
proteins, term suitable, IBD supported by several independent seeds) is recorded
once on mexX: genes/PSEAE/mexX/mexX-notes.md. MexA is also the seed of the
PTN001249140 GO:0140330 IBD (with AcrA and AcrE), supported here by UniProt IDA
(PMID:25901994).